Why the study?
Does ischemic preconditioning prevent Ca2+ paradox-induced changes in cardiac performance and sarcoplasmic reticulum function in isolated perfused hearts?
Does ischemic preconditioning prevent Ca2+ paradox-induced changes in cardiac performance and sarcoplasmic reticulum function in isolated perfused hearts?
Ischemic preconditioning protects against Ca2+ paradox-induced cardiac and sarcoplasmic reticulum dysfunction, with mechanisms partly mediated by adenosine receptors, PKC, and CaMK II.
Ischemic preconditioning may mitigate Ca2+ paradox injury via adenosine-PKC-CaMKII pathways in isolated hearts; leaves open clinical translation.
The effects of ischemic preconditioning (IP) on changes in cardiac performance and sarcoplasmic reticulum (SR) function due to Ca 2+ paradox were investigated. Isolated perfused hearts were subjected to IP (three cycles of 3-min ischemia and 3-min reperfusion) followed by Ca 2+ -free perfusion and reperfusion (Ca 2+ paradox). Perfusion of hearts with Ca 2+ -free medium for 5 min followed by reperfusion with Ca 2+ -containing medium for 30 min resulted in a dramatic decrease in the left ventricular (LV) developed pressure and a marked increase in LV end-diastolic pressure. Alterations in cardiac contractile activity due to Ca 2+ paradox were associated with depressed SR Ca 2+ -uptake, Ca 2+ -pump ATPase, and Ca 2+ -release activities as well as decreased SR protein contents for Ca 2+ -pump and Ca 2+ channels. All these changes due to Ca 2+ paradox were significantly prevented in hearts subjected to IP. The protective effects of IP on Ca 2+ paradox changes in cardiac contractile activity as well as SR Ca 2+ -pump and Ca 2+ -release activities were lost when the hearts were treated with 8-( p-sulfophenyl)-theophylline, an adenosine receptor antagonist; KN-93, a specific Ca 2+ /calmodulin-dependent protein kinase II (CaMK II) inhibitor; or chelerythrine chloride, a protein kinase C (PKC) inhibitor. These results indicate that IP rendered cardioprotection by preventing a depression in SR function in Ca 2+ paradox hearts. Furthermore, these beneficial effects of IP may partly be mediated by adenosine receptors, PKC, and CaMK II.
No takes yet. Share an insight, caveat, or question.
Kawabata et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: